ZYNE — Zynerba Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeSmall Cap
- $70.12m
- $34.15m
Annual cashflow statement for Zynerba Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -39.9 | -32.9 | -51.3 | -37.3 | -35 |
| Depreciation | |||||
| Non-Cash Items | 6.63 | 5.56 | 5.18 | 5.81 | 4.33 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.789 | -7.57 | 4.64 | -2.21 | 7.46 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -32.4 | -34.8 | -41.3 | -33.5 | -23 |
| Capital Expenditures | -0.287 | -0.129 | -0.445 | -0.048 | -0.154 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.287 | -0.129 | -0.445 | -0.048 | -0.154 |
| Financing Cash Flow Items | 0 | -0.13 | -0.854 | -1.09 | -0.543 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 29.9 | 45.2 | 30.9 | 42.2 | 6.01 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.75 | 10.3 | -10.9 | 8.65 | -17.2 |